The choice of confounding factor(s) will depend mainly on the mechanism of the intervention tested, available resources and facilities but we recommend that investigators consider including age, metabolic diseases like diabetes or hypercholesterolemia and/or administration of a platelet P2Y12 inhibitor. Here, P2RY12 is linked to diabetes mellitus.